Merger Talks By SmithKline And Glaxo
Pharmaceutical giants SmithKline Beecham PLC and Glaxo Wellcome PLC, Britain, are near agreement on $80.7 billion merger that will create world's largest drug maker; stumbling block was cleared in large part in early Dec when Jan Leschly, chief executive of SmithKline, who had been seen as largely responsible for management stalemate, announced plans to retire in April (M)
